ConductScience.org, home

Paper28474232

ETS-targeted therapy: can it substitute for MEK inhibitors?

Tetsu O and 1 other. Clin Transl Med, 2017. Cited by 37 papers, by iCite.

Cite this record

ConductScience Library. ETS-targeted therapy: can it substitute for MEK inhibitors? Papers, record 28474232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28474232

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
ETS-targeted therapy: can it substitute for MEK inhibitors?
PubMed
Journal
Clin Transl Med
PubMed
Year
2017
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
37
iCite
Relative citation ratio, by iCite
1.07
iCite
Revised in PubMed
2025-06-24
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tetsu OOsamuhttps://orcid.org/0000-0003-1820-7539
2McCormick FFrank

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R35 CA197709NCI NIH HHSUnited StatesR35CA197709PubMed

Source NIH RePORTER

Download CSV of grants

References108

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
11614856Serum, AP-1 and Ets-1 stimulate the human ets-1 promoter.Nucleic Acids Res1992https://conductscience.org/library/papers/1614856PubMed
211779502Structural studies of Ets-1/Pax5 complex formation on DNA.Mol Cell2001https://conductscience.org/library/papers/11779502PubMed
325399551Improved overall survival in melanoma with combined dabrafenib and trametinib.N Engl J Med2015https://conductscience.org/library/papers/25399551PubMed
419411629Ets1 and Ets2 are required for endothelial cell survival during embryonic angiogenesis.Blood2009https://conductscience.org/library/papers/19411629PubMed
58945521The transcriptional coactivators p300 and CBP are histone acetyltransferases.Cell1996https://conductscience.org/library/papers/8945521PubMed
68052857Transformation of mammalian cells by constitutively active MAP kinase kinase.Science1994https://conductscience.org/library/papers/8052857PubMed
728198367Usp9x regulates Ets-1 ubiquitination and stability to control NRAS expression and tumorigenicity in melanoma.Nat Commun2017https://conductscience.org/library/papers/28198367PubMed
82831462A Harvey-ras responsive transcription element is also responsive to a tumour-promoter and to serum.Nature1988https://conductscience.org/library/papers/2831462PubMed
920534573Ras signaling requires dynamic properties of Ets1 for phosphorylation-enhanced binding to coactivator CBP.Proc Natl Acad Sci U S A2010https://conductscience.org/library/papers/20534573PubMed
1026453958AKT inactivation causes persistent drug tolerance to EGFR inhibitors.Pharmacol Res2015https://conductscience.org/library/papers/26453958PubMed
1115572696Ras/mitogen-activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment.Mol Cell Biol2004https://conductscience.org/library/papers/15572696PubMed
1216533420The effects of a novel MEK inhibitor PD184161 on MEK-ERK signaling and growth in human liver cancer.Neoplasia2006https://conductscience.org/library/papers/16533420PubMed
1324751816Targeting bromodomains: epigenetic readers of lysine acetylation.Nat Rev Drug Discov2014https://conductscience.org/library/papers/24751816PubMed
1422761467First-in-human, phase I dose-escalation study of the safety, pharmacokinetics, and pharmacodynamics of RO5126766, a first-in-class dual MEK/RAF inhibitor in patients with solid tumors.Clin Cancer Res2012https://conductscience.org/library/papers/22761467PubMed
1524450640Recent advances in the structural molecular biology of Ets transcription factors: interactions, interfaces and inhibition.Biochem Soc Trans2014https://conductscience.org/library/papers/24450640PubMed
1625117710Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressor.Cancer Cell2014https://conductscience.org/library/papers/25117710PubMed
1726333361Kinase-independent role for CRAF-driving tumour radioresistance via CHK2.Nat Commun2015https://conductscience.org/library/papers/26333361PubMed
1817721441New androgen receptor genomic targets show an interaction with the ETS1 transcription factor.EMBO Rep2007https://conductscience.org/library/papers/17721441PubMed
1925885538Comparison of MAPK specificity across the ETS transcription factor family identifies a high-affinity ERK interaction required for ERG function in prostate cells.Cell Commun Signal2015https://conductscience.org/library/papers/25885538PubMed
201547944Molecular cloning and characterization of PEA3, a new member of the Ets oncogene family that is differentially expressed in mouse embryonic cells.Genes Dev1992https://conductscience.org/library/papers/1547944PubMed

See all 108 referencesDownload CSV of references

Cited by27

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.

PMIDTitleJournalYearIn PapersSource
41876551Hh and EGFR-Ras signaling promote distinct steps of tumor progression in the Drosophila follicle epithelium.Nat Commun2026https://conductscience.org/library/papers/41876551PubMed
41425714ETS Family Transcription Factors in Gastric Cancer and the Role of ELF3 in the Core Metaplasia Transcription Factor Network.Oncol Res2025https://conductscience.org/library/papers/41425714PubMed
41145444Enhanced ETS1 stability by DNAPKcs orchestrates transcriptional changes during chemoresistance in triple negative breast cancer.NPJ Breast Cancer2025https://conductscience.org/library/papers/41145444PubMed
40214124Identification of novel small molecule inhibitors of ETS transcription factors.FEBS Lett2025https://conductscience.org/library/papers/40214124PubMed
40204967Transcriptional regulation of ETV5 by mitogen-activated protein kinase via ETS-1 in human pancreatic cancer cells.Sci Rep2025https://conductscience.org/library/papers/40204967PubMed
40177537Exploring recent advances in signaling pathways and hallmarks of uveal melanoma: a comprehensive review.Explor Target Antitumor Ther2025https://conductscience.org/library/papers/40177537PubMed
40149711Aberrant Expression and Oncogenic Activity of SPP1 in Hodgkin Lymphoma.Biomedicines2025https://conductscience.org/library/papers/40149711PubMed
39895280PROTACs coupled with oligonucleotides to tackle the undruggable.Bioanalysis2025https://conductscience.org/library/papers/39895280PubMed
39505854Fine-mapping and molecular characterisation of primary sclerosing cholangitis genetic risk loci.Nat Commun2024https://conductscience.org/library/papers/39505854PubMed
37254537ERK/MAPK Signalling Pathway Regulates MMP2 through ETS1 in Renal Clear Cell Carcinoma.Curr Mol Med2024https://conductscience.org/library/papers/37254537PubMed
36504910ETS1 is a prognostic biomarker of triple-negative breast cancer and promotes the triple-negative breast cancer progression through the YAP signaling.Am J Cancer Res2022https://conductscience.org/library/papers/36504910PubMed
36112236The rs1001179 SNP and CpG methylation regulate catalase expression in chronic lymphocytic leukemia.Cell Mol Life Sci2022https://conductscience.org/library/papers/36112236PubMed
35789155Ets1 mediates sorafenib resistance by regulating mitochondrial ROS pathway in hepatocellular carcinoma.Cell Death Dis2022https://conductscience.org/library/papers/35789155PubMed
35141153Identification of a Hypoxia-Related Gene Model for Predicting the Prognosis and Formulating the Treatment Strategies in Kidney Renal Clear Cell Carcinoma.Front Oncol2021https://conductscience.org/library/papers/35141153PubMed
34278178Dual-Specificity Phosphatase 9 Regulates Cellular Proliferation and Predicts Recurrence After Surgery in Hepatocellular Carcinoma.Hepatol Commun2021https://conductscience.org/library/papers/34278178PubMed
33869193Dynamics of m6A RNA Methylome on the Hallmarks of Hepatocellular Carcinoma.Front Cell Dev Biol2021https://conductscience.org/library/papers/33869193PubMed
33143299p53 Loss Mediates Hypersensitivity to ETS Transcription Factor Inhibition Based on PARylation-Mediated Cell Death Induction.Cancers (Basel)2020https://conductscience.org/library/papers/33143299PubMed
32552404Somatic Gain of KRAS Function in the Endothelium Is Sufficient to Cause Vascular Malformations That Require MEK but Not PI3K Signaling.Circ Res2020https://conductscience.org/library/papers/32552404PubMed
32477936ETS1 Suppresses Tumorigenesis of Human Breast Cancer via Trans-Activation of Canonical Tumor Suppressor Genes.Front Oncol2020https://conductscience.org/library/papers/32477936PubMed
31655920Molecular determinants of drug response in TNBC cell lines.Breast Cancer Res Treat2020https://conductscience.org/library/papers/31655920PubMed

See all 27 cited byDownload CSV of cited by

Genes58

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
AR367PubTator's text mininghttps://conductscience.org/library/genes/367NCBI Gene
ARAF369PubTator's text mininghttps://conductscience.org/library/genes/369NCBI Gene
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
BCL2L1110018PubTator's text mininghttps://conductscience.org/library/genes/10018NCBI Gene
BRAF673PubTator's text mininghttps://conductscience.org/library/genes/673NCBI Gene
BRD423476PubTator's text mininghttps://conductscience.org/library/genes/23476NCBI Gene
CAMK2B816PubTator's text mininghttps://conductscience.org/library/genes/816NCBI Gene
CBLL2158506PubTator's text mininghttps://conductscience.org/library/genes/158506NCBI Gene
CCND1595PubTator's text mininghttps://conductscience.org/library/genes/595NCBI Gene
CDK21017PubTator's text mininghttps://conductscience.org/library/genes/1017NCBI Gene
CDK41019PubTator's text mininghttps://conductscience.org/library/genes/1019NCBI Gene
COP164326PubTator's text mininghttps://conductscience.org/library/genes/64326NCBI Gene
CREBBP1387PubTator's text mininghttps://conductscience.org/library/genes/1387NCBI Gene
DUSP41846PubTator's text mininghttps://conductscience.org/library/genes/1846NCBI Gene
DUSP61848PubTator's text mininghttps://conductscience.org/library/genes/1848NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
EP3002033PubTator's text mininghttps://conductscience.org/library/genes/2033NCBI Gene
ERBB22064PubTator's text mininghttps://conductscience.org/library/genes/2064NCBI Gene
ERG2078PubTator's text mininghttps://conductscience.org/library/genes/2078NCBI Gene

See all 58 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28474232

GET https://conductscience.org/api/papers/v1/28474232/references?page=2